DHODH and viral infectious disease: Interestingly, DHODH inhibitors have been approved by the United States Food and Drug Administration (FDA) and are employed for the therapy of autoimmune diseases such as rheumatoid arthritis and multiple sclerosis [23,24] and they are also the objects of active research in cancers [25,26], parasites [27], and virus infections [28].